Compound Detail

CHEMBL5597603

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

COC(=O)[C@]1(C)CC[C@]2(C)CC[C@@]3(C)[C@@](C)(CC=C4c5cc6nc7cc(C(=O)N8CCN(C)CC8)ccc7nc6c(C)c5C=C[C@]43C)[C@@H]2C1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL5597603
Phase	Preclinical
Structure Type	MOL
InChI Key	AFRZXYYTHILDII-PFOFTXBASA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

660.9

MW (Da)

8.09

ALogP

HBA

HBD

75.6

PSA (Å²)

0.20

QED

Ro5 Violations

Rot. Bonds

Availability	Unknown
Chirality	Unknown

First in Class Prodrug

IC50 4 meas. best 5.09

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
MCF7 CHEMBL387	IC50	5.09	5.09	8100.0	1
MCF-10A CHEMBL614321	IC50	5.09	5.09	8200.0	1
A549 CHEMBL392	IC50	5.06	5.06	8700.0	1
Bel-7402 CHEMBL614279	IC50	4.83	4.83	14700.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
MCF7	IC50	=	8100.0	nM	5.09	Antiproliferative activity against human MCF7 cells assessed as reduction in cel...	39106494
MCF-10A	IC50	=	8200.0	nM	5.09	Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability...	39106494
A549	IC50	=	8700.0	nM	5.06	Antiproliferative activity against human A549 cells assessed as reduction in cel...	39106494
Bel-7402	IC50	=	14700.0	nM	4.83	Antiproliferative activity against human Bel-7402 cells assessed as reduction in...	39106494

PubMed	DOI	Target Context	# Activities
39106494	10.1021/acs.jnatprod.4c00373	A549	1
39106494	10.1021/acs.jnatprod.4c00373	MCF7	1
39106494	10.1021/acs.jnatprod.4c00373	Bel-7402	1
39106494	10.1021/acs.jnatprod.4c00373	MCF-10A	1
39106494	10.1021/acs.jnatprod.4c00373	ADMET	1

Data from ChEMBL 36 via Core Engine